SBI Contra Fund Direct Growth NAV at ₹390.08 on 28 October; 5-Year CAGR at 12.95%
Last Updated: 29th October 2026 - 11:24 am
Key Takeaways
- SBI Contra Fund Direct Growth recorded a NAV of ₹390.08 on 28 October 2026, edging down 0.03% during the valuation day.
- The scheme's one-, three- and five-year trailing returns stood at -9.19%, 10.09% and 12.95%, respectively.
- The primary snapshot showed a ₹45,068 crore fund size, a 0.88% expense ratio, a ₹500 minimum SIP and a ₹5,000 minimum lump-sum investment.
- TREPS represented 6.40% of the disclosed portfolio, while HDFC Bank was the largest listed equity position at 4.79%.
SBI Contra Fund Direct Growth closed the 28 October 2026 valuation date with a NAV of ₹390.08. The primary NAV card showed a marginal one-day decline of 0.03%. The scheme is classified as a contra fund, a category that follows a contrarian investment approach rather than mirroring a broad-market portfolio structure.
The scheme's one-year trailing return stood at -9.19%. Its three-year CAGR was 10.09%, and the five-year CAGR was 12.95%. The fund snapshot displayed a size of ₹45,068 crore and a Direct Growth expense ratio of 0.88%. Minimum investment amounts were shown at ₹500 for SIPs and ₹5,000 for a lump-sum transaction.
TREPS was the largest overall disclosed allocation at 6.40%, but this is a short-term liquidity or money-market position rather than a listed equity holding. HDFC Bank was the largest disclosed stock at 4.79%, followed by Reliance Industries at 4.67%, ICICI Bank at 4.36% and Biocon at 3.29%. The five largest displayed entries, including TREPS, represented 23.51% of the portfolio.
Risk statistics displayed on the page included an alpha of 6.20, standard deviation of 4.16, beta of 0.97 and Sharpe ratio of 0.37. The exit-load disclosure showed different charges for redemptions within 30 days and between 30 and 90 days, with no exit load after 90 days, subject to the scheme terms.
The one-day NAV movement was small relative to the differences seen across the scheme's one-, three- and five-year return periods, underlining why these data points describe different measurement horizons rather than interchangeable indicators.
Mutual Fund investments are subject to market risks, read all scheme related documents carefully.
Frequently Asked Questions
What was SBI Contra Fund Direct Growth's NAV on 28 October 2026?
What was the five-year CAGR?
Which was its largest listed equity holding?
- 0 Transaction Cost
- Curated Fund Lists
- 4000+ MF Schemes
- Start SIP with Ease
Trending on 5paisa
Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.
5paisa Capital Ltd